Pfizer’s SWOT analysis: stock faces patent cliff as oncology push drives growth
NeutralFinancial Markets

Pfizer is navigating a challenging landscape as it faces a patent cliff that could impact its stock performance. However, the company's strategic push into oncology is driving growth and may offset some of the potential losses. This situation is significant as it highlights the balancing act pharmaceutical companies must perform between patent expirations and new product development, which ultimately affects investors and the healthcare market.
— Curated by the World Pulse Now AI Editorial System